- Home
- MOLN vs ESP Comparison
MOLN vs ESP Comparison
Compare MOLN & ESP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOLN
- ESP
- Stock Information
- Founded
- MOLN 2004
- ESP 1928
- Country
- MOLN Switzerland
- ESP United States
- Employees
- MOLN N/A
- ESP N/A
- Industry
- MOLN
- ESP Industrial Machinery/Components
- Sector
- MOLN
- ESP Technology
- Exchange
- MOLN Nasdaq
- ESP Nasdaq
- Market Cap
- MOLN 139.5M
- ESP 148.8M
- IPO Year
- MOLN 2021
- ESP N/A
- Fundamental
- Price
- MOLN $3.92
- ESP $36.22
- Analyst Decision
- MOLN Hold
- ESP
- Analyst Count
- MOLN 1
- ESP 0
- Target Price
- MOLN $4.00
- ESP N/A
- AVG Volume (30 Days)
- MOLN 2.5K
- ESP 30.9K
- Earning Date
- MOLN 11-05-2025
- ESP 11-12-2025
- Dividend Yield
- MOLN N/A
- ESP 2.75%
- EPS Growth
- MOLN N/A
- ESP 31.88
- EPS
- MOLN N/A
- ESP 3.02
- Revenue
- MOLN $856,302.00
- ESP $43,950,872.00
- Revenue This Year
- MOLN N/A
- ESP N/A
- Revenue Next Year
- MOLN $1,000.00
- ESP N/A
- P/E Ratio
- MOLN N/A
- ESP $12.06
- Revenue Growth
- MOLN N/A
- ESP 13.46
- 52 Week Low
- MOLN $3.36
- ESP $24.85
- 52 Week High
- MOLN $7.60
- ESP $55.00
- Technical
- Relative Strength Index (RSI)
- MOLN 56.78
- ESP 31.63
- Support Level
- MOLN $3.70
- ESP $36.07
- Resistance Level
- MOLN $3.81
- ESP $39.19
- Average True Range (ATR)
- MOLN 0.09
- ESP 1.59
- MACD
- MOLN 0.01
- ESP -0.01
- Stochastic Oscillator
- MOLN 79.97
- ESP 5.29
About MOLN Molecular Partners AG
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.
About ESP Espey Mfg. & Electronics Corp.
Espey Manufacturing & Electronics Corp designs, develops, tests, and manufactures specialized military and rugged industrial power supplies and transformers for use in harsh or severe environment applications. Its products and solutions include power converters, power conditioning, high-voltage radar, contract manufacturing, custom engineering, and others. The applications of these products include AC and DC locomotives, shipboard power, shipboard radar, airborne power, ground-based radar, and ground mobile power.